Erratum: Parkin attenuates wild-type τ modification in the presence of β-amyloid and α-synuclein (Journal of Molecular Neuroscience DOI: 10.1007/s12031-008-9099-x);Parkin attenuates wild-type τ modification in the presence of β-amyloid and α-synuclein

Journal of Molecular Neuroscience

Volumn 37, Issue 1, 2009, Pages 25-36

  Moussa, Charbel E H ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

4R human ; Dementia; GSK 3 ; Intracellular A 1 42; P301L; Parkin; Parkinsonism; Phosphorylation; Tauopathies; synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; AMYLOID BETA PROTEIN[1-42]; GLYCOGEN SYNTHASE KINASE 3BETA; PARKIN; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PEPTIDE FRAGMENT; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PARKINSONISM; PHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METABOLISM; TAUOPATHY; METABOLISM; NEUROBLASTOMA; PARKINSON DISEASE; PHYSIOLOGY; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; CELL LINE, TUMOR; GLYCOGEN SYNTHASE KINASE 3; HUMANS; NEUROBLASTOMA; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES; UBIQUITIN-PROTEIN LIGASES;

EID: 62649103875     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9167-2     Document Type: Erratum

References (73)

1. I. Alafuzoff K. Iqbal H. Friden R. Adolfsson B. Winbald 1987 Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate analysis Acta Neuropathologica 74 209 225 (Pubitemid 17142259)
2. T. Arriagada J. H. Growdon E. T. Hedley-Whyte B. T. Hyman 1992 Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 42 631 639
3. J. Avila J. Diaz-Nido 2004 Tangling with hypothermia Natural Medicines 10 460 461 (Pubitemid 38667901)
4. M. Baker I. Litvan H. Houlden J. Adamson D. Dickson J. Perez-Tur 1999 Association of an extended haplotype in the tau gene with progressive supranuclear palsy Human Molecular Genetics 8 711 715 (Pubitemid 29139987)
5. C. Bancher C. Brunner H. Lassmann H. Budka K. Jellinger G. Wiche 1989 Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease Brain Research 477 90 99 (Pubitemid 19026942)
6. A. Cedazo-Minguez B. O. Popescu J. M. Blanco-Millan S. Akterin J. J. Pei B. Winbald 2003 Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta Journal of Neurochemistry 87 1152 1164 (Pubitemid 37492856)
7. P. Cohen S. Frame 2001 The renaissance of GSK3 Nature Reviews. Molecular Cell Biology 2 769 776 (Pubitemid 33679839)
8. E. Di Maria M. Tabaton T. Vigo G. Abbruzzese E. Bellone C. Donati 2000 Corticobasal degeneration shares common genetic background with progressive supranuclear palsy Annals of Neurology 47 374 377 (Pubitemid 30141849)
9. D. W. Dickson H. A. Crystal L. A. Mattiace D. M. Masur A. D. Blau P. Davies 1991 Identification of normal and pathological ageing in prospectively studied elderly humans Neurobiology of Aging 13 179 189
10. T. Duka M. Rusnak R. E. Drolet V. Duka C. Wersinger J. L. Goudreau 2006 Alpha-synuclein induces hyper-phosphorylation of tau in the MPTP model of parkinsonism FASEB Journal 20 2302 2312
11. T. Duka A. Sidhu 2006 The neurotoxin, MPP, induces hyper-phosphorylation of tau, in the presence of alpha-synuclein, in SH-SY5Y cells Neurotoxicity Research 10 1 10
12. I. Ferrer M. Barrachina B. Puig 2002 Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration Acta Neuropathologica (Berl.) 104 583 591 (Pubitemid 36075423)
13. M. Frasier M. Walzer L. McCarthy D. Magnuson J. M. Lee C. Haas 2005 Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein Experimental Neurology 192 274 287 (Pubitemid 40347257)
14. B. I. Giasson V. M. Lee J. Q. Trojanowski 2003 Review. Interactions of amyloidogenic proteins Neuromolecular Medicine 4 1-2 49 59
15. M. Goedert M. G. Spillantini R. Jakes D. Rutherford R. A. Crowther 1989 Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 519 526
16. I. Grundke-Iqbal K. Iqbal M. Quinlan Y.-C. Tung M. S. Zaidi H. M. Wisniewski 1986 Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proceedings of the National Academy of Sciences of the United States of America 83 4913 4917 (Pubitemid 16075509)
17. I. Grundke-Iqbal K. Iqbal Y. C. Tung M. Quinlan H. M. Wisniewski L. I. Binder 1986 Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proceedings of the National Academy of Sciences of the United States of America 83 13 4913 4917 (Pubitemid 16075509)
18. F. L. Hanger K. Hughes J. R. Woodgett J.-P. Brion B. H. Anderton 1992 Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired filament epitopes and neuronal localization of the kinase Neuroscience Letters 147 58 62
19. J. Hardy 2005 Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration Biochemical Society Transactions 33 578 580 (Pubitemid 41160813)
20. D. G. Healy P. M. Abou-Sleiman A. J. Lees J. P. Casas N. Quinn K. Bhatia 2004 Tau gene and Parkinson's disease: a case-control study and meta-analysis Journal of Neurology, Neurosurgery and Psychiatry 75 962 965 (Pubitemid 38869606)
21. M. Hetman J. E. Cavanaugh D. Kimelmann Z. Xia 2000 Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal Journal of Neuroscience 20 2567-2574 (Pubitemid 30220344)
22. A. Himmler D. Dreschel M. W. Kirschner D. W. Martin 1989 Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains Molecular and Cellular Biology 9 1381-1388 (Pubitemid 19095177)
23. M. Hong D. C. Chen P. S. Klein V. M. Lee 1997 Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase 3 Journal of Biological Chemistry 272 25326 25332 (Pubitemid 27415724)
24. M. Hutton C. L. Lendon P. Rizzu M. Baker S. Froelich H. Houlden 1998 Association of missense and 5¢-splice-site mutations in tau with the inherited dementia FTPD-17 Nature 393 702 705 (Pubitemid 28289662)
25. Y. Imai M. Soda R. Takahashi 2000 Parkin suppresses unfolded protein stress-induced cell death through an E3-protein ligase activity Journal of Biological Chemistry 275 35661 35664
26. K. Iqbal I. Grundke-Iqbal 1992 Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease Molecular Neurobiology 5 399 410
27. K. Iqbal I. Grundke-Iqbal A. J. Smith L. George Y.-C. Tung T. Zaidi 1989 Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 86 5646 5650
28. K. Iqbal I. Grundke-Iqbal T. Zaidi P. A. Merz G. Y. Wen S. S. Shaikh 1986 Defective brain microtubule assembly in Alzheimer's disease Lancet 2 421 426 (Pubitemid 16047953)
29. K. Ishiguro A. Omori K. Saro K. Imahori T. Uchida 1991 A serine/threonine proline kinase activity is induced in the tau protein kinase fraction forming a paired helical filament epitope Neuroscience Letters 128 195 198
30. K. Ishiguro A. Shiratsuchi K. Sato M. Hori H. Karaki S. Watabe 1993 Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments FEBS Letters 325 167 172 (Pubitemid 23186470)
31. T. Ishizawa P. Mattila P. Davies D. Wang D. W. Dickson 2003 Colocalization of tau and alpha-synuclein epitopes in Lewy bodies Journal of Neuropathology and Experimental Neurology 62 94 389 397 (Pubitemid 36403039)
32. S. Johansson A. Jamsa M. Vasange B. Winbald J. Luthman R. F. Cowburn 2006 Increased tau phosphorylation at the ser396 epitope after amyloid beta-exposure in organotypic cultures Neuroreport 17 907 911 (Pubitemid 43869957)
33. T. Kitada S. Asakawa N. Hattori H. Matsumine Y. Yamamura S. Minoshima 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 605 608 (Pubitemid 28207717)
34. R. L. Klein R. D. Dayton K. M. Henderson L. Petrucelli 2006 Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model Neuroscience Letters 401 130 135
35. R. L. Klein R. D. Dayton W. L. Lin D. W. Dickson 2005 Tau gene transfer, but not alpha-synuclein, induces progressive dopamine neuron degeneration and rotational behavior in the rat Neurobiology of Disease 20 64 73 (Pubitemid 41219203)
36. R. L. Klein W. L. Lin D. W. Dickson J. Lewis M. Hutton K. Duff 2004 Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau American Journal of Pathology 164 347-353 (Pubitemid 38364618)
37. E. Kopke Y.-C. Tung S. Shaikh A. C. Alonso 1993 Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease Journal of Biological Chemistry 268 24374-24384 (Pubitemid 23335430)
38. R. Layfield J. R. Cavey J. Lowe 2003 Role of the ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative diseases Ageing Research Reviews 2 4 343 356 (Pubitemid 37159397)
39. M. D. Ledesma L. Correas J. Avila J. Diaz-Nido 1992 Implication of brain cdc2 and MAP kinases in the phosphorylation of tau protein in Alzheimer's disease FEBS Letters 308 218 224
40. K. Leroy A. Boutajangout M. Authelet J. R. Woodgett B. H. Anderton J. P. Brion 2002 The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease Acta Neuropathologica (Berl.) 103 91 99 (Pubitemid 36067485)
41. J. Lewis E. McGowan J. Rockwood H. Melrose P. Nacharaju M. Van Slegtenhorst 2000 Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nature Genetics 25 402 405 (Pubitemid 32983430)
42. S. M. Lippa C. F. Lippa H. Mori 2005 Alpha-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level American Journal of Alzheimer's Disease and other Dementias 20 5 315 318 (Pubitemid 41502373)
43. S. J. Liu A. H. Zhang H. L. Li O. Wang H. M. Deng W. J. Netzer 2003 Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory Journal of Neurochemistry 87 1333 1344 (Pubitemid 38020568)
44. Liu, G.-P., Zhang, Y., Yao, X.-Q., Zhang, C.-E., Fang, J., Wang, Q., et al. (2007). Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiology of Aging. doi: 10.1016/j.neurobiolaging.2007.03.012 .
45. C. Lo Bianco L. S. Schneider M. Bauer A. Sadaji A. Brice T. Iwatsubo 2004 Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 101 50 17510 17515 (Pubitemid 39657434)
46. S. Lovestone C. H. Reynolds D. Latimer D. R. Davis B. H. Anderton J. M. Gallo 1994 Alzheimer's disease like phosphorylation of the microtubule- associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells Current Biology 4 1077 1086 (Pubitemid 124001594)
47. J. J. Lucas F. Henandez P. Gomez-Ramos M. A. Moran R. Hen J. Avila 2001 Decreased nuclear beta-catenin, tau hyper-phosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice EMBO Journal 20 27 39 (Pubitemid 32099099)
48. C. B. Lucking A. Durr V. Bonifati J. Vaughan G. De Michele T. Gasser 2000 Association between early onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group New England Journal of Medicine 342 1560 1567
49. Q. L. Ma G. P. Lim M. E. Harris-White F. Yang S. S. Ambegaokar O. J. Ubedo 2006 Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro Journal of Neuroscience Research 83 374 384 (Pubitemid 43184401)
50. E. R. Martin W. K. Scott M. A. Nance R. L. Watts J. P. Hubble W. C. Koller 2001 Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson's disease Journal of the American Medical Association 286 2245 2250 (Pubitemid 33063146)
51. J. R. Munoz-Montano F. J. Moreno J. Avila J. Diaz-Nido 1997 Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons FEBS Letters 411 183 188 (Pubitemid 27301451)
52. B. Murray T. Lynch M. Farrell 2005 Clinicopathological features of the tauopathies Biochemical Society Transactions 33 part 4 595 599 (Pubitemid 41160817)
53. P. Nacharaju J. Lewis C. Easson S. Yen J. Hackett M. Hutton 1999 Accelerated filament formation from tau protein with specific FTPD-17 missense mutations FEBS Letters 447 195 1999 (Pubitemid 29146084)
54. Z. Nemes B. Devreese P. M. Steinert J. Van Beeumen L. Fesus 2004 Cross-linking of ubiquitin, HSP27, parkin and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles FASEB Journal 18 10 1135-1137 (Pubitemid 39561548)
55. R. L. Nussbaum C. F. Ellis 2003 Alzheimer's disease and Parkinson's disease New England Journal of Medicine 348 14 1256 1364 (Pubitemid 36384104)
56. D. C. Paviour A. J. Lees K. A. Josephs T. Ozawa M. Ganguly C. Strand 2004 Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy Brain 127 Pt 11 2441 2451 (Pubitemid 39472972)
57. J. J. Pei E. Braak H. Braak I. Grandke-Igbal K. Iqbal B. Winbald 1999 Distribution of active glycogen synthase kinase 3-β (GSK-3β) in brains staged for Alzheimer's disease neurofibrillary changes Journal of Neuropathology and Experimental Neurology 58 1010 1019 (Pubitemid 29441929)
58. O. Pletnikova N. West M. K. Lee G. L. Rudow R. L. Skolasky T. M. Dawson 2005 Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases Neurobiology of Aging 26 8 1183 1192 (Pubitemid 40726011)
59. A. Popescu C. F. Lippa V. M. Lee J. Q. Trojanowski 2004 Lewy bodies in the amygdala: increase of α-synuclein aggregates in neurodegenerative diseases with tau-based inclusions Archivos de Neurobiología 61 12 1915 1919 (Pubitemid 39612952)
60. K. Rosen V. Veereshwarayya E.-h. C. Moussa Q. Fu S. M. Goldberg G. M. Schlossmacher 2006 Parkin protects against mitochondrial toxins and β-amyloid accumulation in skeletal muscle cells Biological Chemistry 281 18 12809 12816 (Pubitemid 43855373)
61. M. P. Sanchez I. Gonzalo J. Avila J. G. De Yebenes 2002 Progressive supranuclear palsy and tau hyper-phosphorylation in a patient with C212Y parkin mutation Journal of Alzheimer's Disease 4 5 399-404 (Pubitemid 35397805)
62. M. Schafer S. Goodenough B. Moosmann C. Behl 2004 Inhibition of glycogen synthase kinase 3B is involved in the resistance to oxidative stress in neuronal HT22 cells Brain Research 1005 84 89 (Pubitemid 38388403)
63. A. Sengupta J. Kabat M. Novak Q. Wu I. Grundke-Iqbal K. Iqbal 1998 Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules Archives of Biochemistry and Biophysics 357 299 309 (Pubitemid 28419212)
64. H. Shimura N. Hattori S. Kubo Y. Mizuno S. Asakawa S. Minoshima 2000 Familial parkinsonism disease gene product, parkin, is a ubiquitin-protein ligase Nature Genetics 25 302 305 (Pubitemid 30437317)
65. T. Suhara J. Magrane K. Rosen R. Christensen H. S. Kim B. Zheng 2003 Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signaling-dependent mechanism Neurobiology of Aging 24 437 451 (Pubitemid 36205050)
66. A. Takashima 2006 GSK-3 is essential in the pathogenesis of Alzheimer's disease Journal of Alzheimer's Disease 9 309-317 (Pubitemid 44253325)
67. A. Takashima T. Honda K. Yasutake G. Michel O. Murayama M. Murayama 1998 Activation of tau protein I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons Neuroscience Research 31 317 323 (Pubitemid 28446014)
68. A. Takashima K. Noguchi G. Michel M. Mercken M. Hochi K. Ishiguro 1996 Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β Neuroscience Letters 203 33 36 (Pubitemid 126335008)
69. J.-Z. Wang I. Grudnke-Iqbal K. Iqbal 2007 Kinases and phosphatases and tau sites involved in Alzheimer's neurofibrillary formation European Journal of Neuroscience 25 59-68 (Pubitemid 46098893)
70. D. Yancopoulou J. H. Xuereb R. A. Crowther J. R. Hodges M. G. Sppillantini 2005 Tau and alpha-synuclein inclusions in a familial frontotemporal dementia and progressive aphasia Journal of Neuropathology and Experimental Neurology 64 3 245-253 (Pubitemid 40389233)
71. S. G. Younkin 1995 Evidence that Abeta 42 is the real culprit in Alzheimer's disease Annals of Neurology 37 3 287 288
72. Y. Zhang J. Gao K. K. Chung H. Huang V. L. Dawason T. M. Dawson 2000 Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic associated protein CDCrel-1 Proceedings of the National Academy of Sciences of the United States of America 97 13354 13359
73. W. H. Zheng S. Bastianetto F. Mennicken W. Ma S. Kar 2002 Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures Neuroscience 115 201 211 (Pubitemid 35232701)